Search results
30 minutes of exercise a day reduces the risk of cancer
Hardwood Paroxysm· 5 hours agoRegular physical activity is, of course, the best complement to a healthy diet and is essential for keeping muscles and joints in shape. What’s new is that, according to the Spanish Society ...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
The Marysville Advocate· 2 days agoUpdated results reinforce the potential of TAR-210 to transform treatment of non–muscle-invasive bladder cancer with fibroblast growth factor receptor (FGFR) alterations
Swing Against Cancer 2024 breaks records, raises $220,000 for research
The Desert Sun via Yahoo News· 4 days agoBob Corwin's cancer story began with a breast cancer diagnosis in 2004 — one of the few male breast ...
The nine things every man should know about prostate cancer
The Telegraph via Yahoo News· 6 days agoOpening up about their below-the-belt health is not a conversation every man wants to have with his...
Advisers Giving Back: Petros Koumantaros | PLANADVISER
PLANADVISER· 24 hours agoPetros Koumantaros’ father, Pano, came to the U.S. from Greece in 1970 to pursue the American dream....
Causes and symptoms of the most common cancers in each age group revealed
The US Sun· 3 days agoTHERE are a thousand new cancer cases diagnosed every day in the UK – but some types can be avoided...
New mRNA cancer vaccine triggers immune system to fight aggressive brain tumour
PA Media: Science via Yahoo News· 6 days agoThe research is published in the journal Cell, and comes after the trial for the world’s first...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via AOL· 6 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
...Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer...
Benzinga· 3 days agoUroGen Pharma Ltd. URGN, a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results ...
The future of oncology therapies: Stingray Therapeutics’ immune-boosting breakthrough
Digital Journal· 7 days agoCurrent immune oncology treatments face a critical limitation: they are only effective in about half...
